| 4ZZN | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | CME, CQ8, SO4 | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Structure-guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2., Ward RA, Colclough N, Challinor M, Debreczeni J, Eckersley K, Fairley G, Feron L, Flemington V, Graham MA, Greenwood R, Hopcroft P, Howard TD, James M, Jones CD, Jones CR, Renshaw J, Roberts K, Snow L, Tonge M, Yeung K, J Med Chem. 2015 May 15. PMID:25977981 | ||||||||||||||
| Data retrieval |
![]() |
| View 4ZZN in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |